1)Kopetz S, Chang GJ, Overman MJ, et al:Improved survival metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677-3683, 2009
2)Sobin LH, Gospodarowicz MK, Wittekind C:TNM Classification of Malignant Tumors. UICC International Union Against Cancer. 7th ed. Hoboken, Wiley-Blackwell, 2009
3)大腸癌研究会(編):全国大腸癌登録調査報告.第1~30号,1985~2004
4)大腸癌研究会(編):大腸癌取扱い規約.第7版.金原出版,2006, p 15
5)日本胃癌学会(編):胃癌取扱い規約.第14版.金原出版,2010
6)Pestieau SR, Sugarbaker PH:Treatment of primary colon cancer with peritoneal carcinomatosis:comparison of concomitant vs. delayed management. Dis Colon Rectum 43:1341-1346, 2000
7)Verwaal VJ, Van Ruth S, De Bree E, et al:Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737-3743, 2003
8)Verwaal VJ, Bruin S, Boot H, et al:8-year follow-up of randomized trial:cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426-2432, 2008
9)Franko J, Ibrahim Z, Gusani NJ, et al:Cytoreduction surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 116:3756-3762, 2010
10)Glehen O, Kwiatkowski F, Sugarbaker PH, et al:Cytoreduction surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer:a multi-institutional study. J Clin Oncol 22:3284-3292, 2004
11)大腸癌研究会(編):大腸癌同時性遠隔転移頻度.大腸癌治療ガイドライン医師用2010年版.金原出版,2010, p 60
12)van Leeuwen BL, Graf W, Pahlman L, et al:Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 15:745-753, 2008
13)Gusani NJ, Cho SW, Colovos C, et al:Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 15:754-763, 2008
14)Elias D, Lefevre JH, Chevalier J, et al:Complete cytoreduction surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681-685, 2009
15)de Bree E, Witkamp AJ, Zoetmulder FA:Intraperitoneal chemotherapy for colorectal cancer. J Surg Oncol 79:46-61, 2002
16)Cavaliere F, De Simone M, Virzì S, et al:Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy:Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol 37:148-154, 2011
17)Quenet F, Goéré D, Mehta SS, et al:Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254:294-301, 2011
18)Glehen O, Gilly FN, Boutitie F, et al:Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy:a multi-institutional study of 1, 290 patients. Cancer 116:5608-5618, 2010
19)Cavaliere F, Valle M, De Simone M, et al:120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia:a S.I.T.I.L.O. multicentric study. In Vivo 20:747-750, 2006
20)Franko J, Ibrahim Z, Gusani NJ, et al:Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 116:3756-3762, 2010
21)Bruin SC, Verwaal VJ, Vincent A, et al:A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol 17:2330-2340, 2010
22)Yan TD, Black D, Savady R, et al:Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011-4019, 2006
. Colon Cancer, Version 3, 2013(www.nccn.org)
24)Jacquet P, Sugarbaker PH:Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374, 1996
25)Sugarbaker PH:Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43(Suppl):S15-S25, 1999
26)Gilly FN, Carry PY, Sayag AC, et al:Regional chemotherapy(with mitomycin C)and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124-129, 1994
27)Harmon RL, Sugarbaker PH:Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2:3, 2005
28)Witkamp AJ, de Bree E, Kaag MM, et al:Extensive cytoreduction surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979-984, 2001
29)亀岡信悟,板橋道朗:高度進行大腸癌治療の最前線.外科切除例.腹膜転移に対する外科治療.消外24:1349-1357, 2001
30)平井 孝,加藤知行,金光幸秀:腹膜播種の診断と治療.大腸癌腹膜播種性転移の治療とその成績.外科66:921-925, 2004
31)堤 荘一,浅尾高行,桑野博行:癌の播種性病変の病態と診断・治療.大腸癌腹膜播種の診断と治療:臨外61:775-778, 2006
32)Koppe MJ, Boerman OC, Oyen WJ, et al:Peritoneal carcinomatosis of colorectal origin:incidence and current treatment strategies. Ann Surg 243:212-222, 2006
33)Sadahiro S, Suzuki T, Maeda Y, et al:Prognostic factors in patients with synchronous peritoneal carcinomatosis(PC)caused by a primary cancer of the colon. J Gastrointest Surg 13:1593-1598, 2009
34)山口智弘,絹笠祐介,塩見明生,他:腹膜播種を伴う原発性大腸癌に対する外科的治療の成績.日消外会誌44:1231-1238, 2011
35)Jayne DG, Fook S, Loi C, et al:Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545-1550, 2002
36)山口由美,柴田俊輔,石黒 稔,他:腹膜播種を伴う大腸癌切除例の臨床病理学的検討.臨外59:181-186, 2004
37)横溝 肇,吉松和彦,大澤岳史,他:腹膜播種性転移を伴う大腸癌の治療成績と治療方針.日臨外会誌69:2468-2473, 2008
38)小澤平太,固武健二郎:腹膜転移,骨転移,脳転移の頻度と変遷.大腸癌Frontier,2013(印刷中)
39)Piso P, Dirk A:Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer. Dtsch Arztebl Int 108:802-808, 2011